People · Operator

Daniel Mendez

Named in public records as an officer, director or promoter · active 2013–2013 · Healthtech

1
Companies
2
Filings
$8.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Invictus Medical, Inc.HealthtechSeed$8.9M$34.9M2013
Operator network

Daniel Mendez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Tom Roberts · 6 companies · 1 sharedTom RobertsChris D. Gilmer · 1 companies · 1 sharedChris D. GilmerChris Gilmer · 1 companies · 1 sharedChris GilmerDennis A. Kane · 1 companies · 1 sharedDennis A. KaneDennis M. Kane · 1 companies · 1 sharedDennis M. KaneEric D. Eisbrenner · 1 companies · 1 sharedEric D. EisbrennerEric Eisbrenner · 1 companies · 1 sharedEric EisbrennerEric M. Eisbrenner · 1 companies · 1 sharedEric M. EisbrennerGeorge A. Hutchinson · 1 companies · 1 sharedGeorge A. Hutchin…George Hutchinson · 1 companies · 1 sharedGeorge HutchinsonLynn D. Nauss · 1 companies · 1 sharedLynn D. NaussLynne D. Nauss · 1 companies · 1 sharedLynne D. NaussRandall A. Cole · 1 companies · 1 sharedRandall A. ColeStephen M. Dufilho · 1 companies · 1 sharedStephen M. DufilhoInvictus Medical, Inc. · $8.9M raisedInvictus Medical, Inc.Daniel MendezDM
Daniel Mendez Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Daniel Mendez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Tom Roberts16
Chris Gilmer11
Eric Eisbrenner11
George A. Hutchinson11
Eric D. Eisbrenner11
Lynne D. Nauss11
Stephen M. Dufilho11
Chris D. Gilmer11
Randall A. Cole11
Dennis A. Kane11
Dennis M. Kane11
Eric M. Eisbrenner11
George Hutchinson11
Lynn D. Nauss11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.